Cost-effectiveness analysis of 23-valent pneumococcal polysaccharide vaccine for elderly in Zhejiang province, China. [PDF]
Yu Z, Han S, Hu Y.
europepmc +1 more source
Factors associated with severe pneumonia in adults hospitalised with community-acquired pneumonia in Mongolia. [PDF]
Simkiss A +11 more
europepmc +1 more source
Association between introduction of 13-valent pneumococcal conjugate vaccine and burden of hospitalized adult pneumococcal disease in Hong Kong - A retrospective database study. [PDF]
Yu Q +8 more
europepmc +1 more source
A Rare Case of Invasive Pneumococcal Disease Presenting With Pneumonia, Meningitis, Septic Arthritis, and Cerebral Infarcts. [PDF]
Waraich H, Haq H, Abdullah H.
europepmc +1 more source
Exploring the impact of oral health and vaccination on pneumonia-causing bacteria: insights from predictive modeling. [PDF]
Whealy RN +11 more
europepmc +1 more source
Global Assessment of Health Utilities Associated with Pneumococcal Disease in Adults: Targeted Literature Reviews. [PDF]
Huang M +9 more
europepmc +1 more source
Changes in 23-valent pneumococcal polysaccharide vaccination rate and associated factors in 2022 and 2024 among community-based older adults in Shanghai, China. [PDF]
Jia Y +5 more
europepmc +1 more source
No culture? No problem: Clinical utility and pitfalls of non-culture diagnostics for pneumococcal parapneumonic effusions. [PDF]
Dimeas IE +3 more
europepmc +1 more source
The impact of pneumococcal conjugate vaccines on disease epidemiology, serotype distribution, and antimicrobial resistance in children. A 25-year observational study in Athens, Greece (1996-2021). [PDF]
Syriopoulou VP +18 more
europepmc +1 more source

